Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February

Capricor Therapeutics CAPR recently provided a regulatory update on its Biologics License Application (BLA) for Deramiocel, following recent interactions with the FDA. After reviewing topline data

Zacks 
0 21.01.26